| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 09/16/2004 | DE102004010086A1 Substiuierte Piperidinderivate Substiuierte piperidine |
| 09/16/2004 | CA2517081A1 Nitrogen-containing heterocyclic derivatives having 2-6, disubtituted styryl |
| 09/15/2004 | EP1457491A1 Method for making piperidone ketals using polyphosphoric acid |
| 09/15/2004 | EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity |
| 09/15/2004 | EP1457487A1 Process for production of optically active cis-piperidine derivatives |
| 09/15/2004 | EP1456198A1 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases |
| 09/15/2004 | EP1456173A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
| 09/15/2004 | EP1456171A1 Substituted cyclohexane derivatives |
| 09/15/2004 | EP1455787A1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders |
| 09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
| 09/15/2004 | CN1529756A Steroselective preparation of cyclic L-amino acids |
| 09/15/2004 | CN1529600A Use of NK-1-receptor antagonists tomodify unwanted behavior indogs, casts and horses |
| 09/15/2004 | CN1529599A Acylic piperazine and piperidine derivatives which are used for treating neuronal damage |
| 09/15/2004 | CN1528747A Immunoregulator for inhibiting interleukin-4, stimulus g interferon and preparing method thereof |
| 09/15/2004 | CN1166640C Substituted 1,2,3,4,5,6-hyxahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments |
| 09/15/2004 | CN1166632C New hydroxamic acid compounds, their preparation method and medicine composition containing them |
| 09/15/2004 | CN1166631C S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 09/15/2004 | CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
| 09/14/2004 | US6790854 Diphenylalkylamine derivatives useful as opioid receptor agonists |
| 09/14/2004 | US6790834 Cytostatic agents |
| 09/14/2004 | CA2458736A1 Method for making piperidone ketals using polyphosphoric acid |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/14/2004 | CA2280708C Cetp activity inhibitors |
| 09/10/2004 | WO2004076434A1 Dipeptidyl peptidase inhibitors |
| 09/10/2004 | WO2004076433A1 Dipeptidyl peptidase inhibitors |
| 09/10/2004 | WO2004076419A1 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines |
| 09/10/2004 | WO2004076418A1 Ligands that modulate lxr-type receptors |
| 09/10/2004 | WO2004076413A2 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| 09/10/2004 | WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | WO2004076402A1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004043922A8 Method of preparation of terfenadine and its derivatives |
| 09/10/2004 | WO2004041776A3 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | WO2003079984A3 Substituted tetracycline compounds |
| 09/10/2004 | WO2002099045A3 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone |
| 09/10/2004 | CA2517334A1 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines |
| 09/10/2004 | CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | CA2516626A1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments |
| 09/10/2004 | CA2515963A1 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| 09/10/2004 | CA2512886A1 Ligands that modulate lxr-type receptors |
| 09/09/2004 | US20040176606 Salt formation with benzooic acid in dilluent or carrier for heart disease and hypotensive agents |
| 09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
| 09/09/2004 | US20040176553 4-Imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176419 particularly chronic obstructive pulmonary disease (COPD), asthma or a related pulmonary disease such as chronic bronchitis or allergic rhinitis |
| 09/09/2004 | US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase |
| 09/09/2004 | US20040176412 Process for the preparation of threo-methylphenidate hydrochloride |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176410 Analgesics and antiallodynia agents, e.g., 1-[2-(4-cyanophenyl)ethyl]-4-(4-nitrophenoxymethyl)piperidin-4-ol and analogues; oral administration to treat neuropahic pain; side effect reduction; highly efficient |
| 09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
| 09/09/2004 | DE10308352A1 Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Arylcycloalkylderivate with branched side chains, to processes for their preparation and their use as medicaments |
| 09/09/2004 | DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments |
| 09/08/2004 | EP1453825A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor |
| 09/08/2004 | EP1453806A1 Aminotetralin derivatives as muscarinic receptor antagonist |
| 09/08/2004 | EP1453805A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 09/08/2004 | EP1453804A2 Ccr-3 receptor antagonists vii |
| 09/08/2004 | EP1453792A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453509A2 Polymorphs of fexofenadine base |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | EP1289972B1 Serine protease inhibitors |
| 09/08/2004 | EP1289950B1 Serine protease inhibitors |
| 09/08/2004 | EP1191932B1 Production of agglomerates of inogatran and the compound inogatran anhydrate |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | EP1156038B1 2-n-substituted or unsubstituted-2-amino-5-methylpiperidine-3,4-diols and processes for the preparation thereof |
| 09/08/2004 | EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 09/08/2004 | EP0950052B1 Method for preparing a tetrahydropyridin derivative |
| 09/08/2004 | CN1527876A Compounds, compositions, and methods for controlling biofilms |
| 09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527818A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527817A Method for preparing 4-methylamino-4-phenylpiperidine |
| 09/08/2004 | CN1165524C Process for purifying sterically hindered 4-amino-piperidines |
| 09/08/2004 | CN1165523C Process for preparation of 1-alkyl-3-methylpiperidone-2 and 1-alkyl-5-methylpiperidone-2 |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/07/2004 | US6787650 Ccr5 antagonistic activity; such as n-(3-(4-benzyl-1-piperidinyl)propyl)-n'-4-chlorophenyl)-n-phenylurea |
| 09/07/2004 | US6787563 Antidiarrhea agents; gastrointestinal disorders |
| 09/07/2004 | US6787560 Serotonin reuptake inhibitor |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787522 Antibacterial agents |
| 09/07/2004 | CA2093770C Aspartic acid derivatives, their preparation and use |
| 09/02/2004 | WO2004074812A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004074276A1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 09/02/2004 | WO2004074275A1 Indazolamides with analgesic activity |
| 09/02/2004 | WO2004074256A1 Tetrahydroisoquinolinyl sulfamic acids |
| 09/02/2004 | WO2004074251A1 Derivatives of azasugars as anticancer agents |
| 09/02/2004 | WO2004074246A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004074238A1 Phenethylamino sulfamic acids |
| 09/02/2004 | WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | WO2004060859A3 Novel amides that activate soluble guanylate cyclase |
| 09/02/2004 | WO2004056319A3 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171868 Method for producing (meth) acrylic acid esters |
| 09/02/2004 | US20040171837 Using a protected 4-piperidone compound |
| 09/02/2004 | US20040171836 Method for producing optical-active cis-piperidine derivatives |